Salim Yalcin Inan

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 4

Top Topics

High Resolution

Obsessive Compulsive Disorder

Top Venues

Molecular neurobiology

Parkinson's disease

Metabolic brain disease

This page only lists publications with an associated author ORCID identifier.

Publications

Salim Yalcin Inan, Sendegul Yildirim, Gamze TanriÖver, Barkin Ilhan
P/Q type (Ca v 2.1) Calcium Channel Blocker ω-Agatoxin IVA Alters Cleaved Caspase-3 and BDNF Expressions in the Rat Brain and Suppresses Seizure Activity. Molecular neurobiology (2023)
Ebru Guclu, Salim Yalcin Inan, Hasibe Cingilli Vural
The Sirtuin 2 Inhibitor AK-7 Leads to an Antidepressant-Like Effect in Mice via Upregulation of CREB1, BDNF, and NTRK2 Pathways. Molecular neurobiology 59 (11) (2022)
Burak Cem Soner, Eda Acikgoz, Salim Yalcin Inan, Şule Ayla, Ayse Saide Sahin, Gulperi Oktem
Neuroprotective Effect of Intrastriatal Caffeic Acid Phenethyl Ester Treatment in 6-OH Dopamine Model of Parkinson's Disease in Rats. Parkinson's disease 2021 (2021)
Salim Yalcin Inan, Burak Cem Soner, Ayse Saide Sahin
Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson's disease. Metabolic brain disease 31 (4) (2016)